---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042204"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T23:06:01.688170+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical appoints Dr. Juan Diaz-Cartelle as CMO effective Dec 1, 2023

## Summary
- Dr. Diaz-Cartelle was previously Senior Medical Director at Boston Scientific (14 yrs) and Executive Medical Director at Haemonetics.
- Base salary $350,000, target bonus up to 30% of salary, and 25,000 stock options vesting over three years.
- He will lead U.S. clinical trials for the LIBERTY Endovascular Robotic Surgical System and FDA regulatory process.
- Succeeds Dr. Eyal Morag; company shifts focus from R&D in Israel to U.S.-based clinical and commercial activities.

## SEC filing metadata
- accession: 0001493152-23-042204
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/0001493152-23-042204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042204
- JSON: https://secwatch.observer/filing/0001493152-23-042204.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042204.txt

## Key facts
- Executive change
  Dr. Juan Diaz-Cartelle was appointed as Chief Medical Officer at Microbot Medical Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On November 21, 2023, Microbot Medical Inc. (the “Company”) announced the appointment of Dr. Juan Diaz-Cartelle, age 48, as the Company’s new Chief Medical Officer (“CMO”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/0001493152-23-042204-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.